These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 2507435
21. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS. J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438 [Abstract] [Full Text] [Related]
22. The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration. Fulghesu AM, Lanzone A, Apa R, Guido M, Ciampelli M, Cucinelli F, Caruso A, Mancuso S. J Endocrinol Invest; 1997 Mar; 20(7):368-73. PubMed ID: 9309533 [Abstract] [Full Text] [Related]
23. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle. Nippoldt TB, Reame NE, Kelch RP, Marshall JC. J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593 [Abstract] [Full Text] [Related]
24. [Study of the correlation between gonadotropin- and prolactin-releasing systems in women in the luteal phase and early pregnancy]. Kubota T, Nishi N, Saito M, Suzuki A, Yaoi Y, Kumasaka T. Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):545-53. PubMed ID: 3084684 [Abstract] [Full Text] [Related]
25. Progesterone stimulates luteinizing hormone secretion by acting directly on the pituitary. Couzinet B, Brailly S, Bouchard P, Schaison G. J Clin Endocrinol Metab; 1992 Feb; 74(2):374-8. PubMed ID: 1730816 [Abstract] [Full Text] [Related]
26. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia. Larrea F, Sandoval JL, Salinas E, Franco-Rodriguez VA, Méndez I, Ulloa-Aguirre A. Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944 [Abstract] [Full Text] [Related]
27. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human. Hall JE, Bhatta N, Adams JM, Rivier JE, Vale WW, Crowley WF. J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489 [Abstract] [Full Text] [Related]
28. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease. Christman GM, Randolph JF, Kelch RP, Marshall JC. J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845 [Abstract] [Full Text] [Related]
29. [Pulsatile secretion of ovarian steroids in the mid-luteal phase of the menstrual cycle]. Kajimura H. Nihon Naibunpi Gakkai Zasshi; 1990 Feb 20; 66(2):134-44. PubMed ID: 2110081 [Abstract] [Full Text] [Related]
30. Synchronous secretion of luteinizing hormone and prolactin in the human luteal phase: neuroendocrine mechanisms. Braund W, Roeger DC, Judd SJ. J Clin Endocrinol Metab; 1984 Feb 20; 58(2):293-7. PubMed ID: 6420434 [Abstract] [Full Text] [Related]
31. Effect of gonadotropin-releasing hormone (GnRH) pulse frequency on serum and pituitary concentrations of luteinizing hormone and follicle-stimulating hormone, GnRH receptors, and messenger ribonucleic acid for gonadotropin subunits in cows. Vizcarra JA, Wettemann RP, Braden TD, Turzillo AM, Nett TM. Endocrinology; 1997 Feb 20; 138(2):594-601. PubMed ID: 9002991 [Abstract] [Full Text] [Related]
32. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. Lasley BL, Wang CF, Yen SS. J Clin Endocrinol Metab; 1975 Nov 20; 41(5):820-6. PubMed ID: 1102551 [Abstract] [Full Text] [Related]
33. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus. Djursing H, Hagen C, Nyholm HC, Carstensen L, Andersen AN. J Clin Endocrinol Metab; 1983 May 20; 56(5):1016-21. PubMed ID: 6403566 [Abstract] [Full Text] [Related]
34. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle. Soules MR, McLachlan RI, Ek M, Dahl KD, Cohen NL, Bremner WJ. J Clin Endocrinol Metab; 1989 Oct 20; 69(4):804-12. PubMed ID: 2506214 [Abstract] [Full Text] [Related]
35. Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women. Lemay A, Faure N, Labrie F. Fertil Steril; 1982 Feb 20; 37(2):193-200. PubMed ID: 6800846 [Abstract] [Full Text] [Related]
36. Prolongation of the bovine estrous cycle with a gonadotropin-releasing hormone analog. Milvae RA, Murphy BD, Hansel W. Biol Reprod; 1984 Nov 20; 31(4):664-70. PubMed ID: 6439255 [Abstract] [Full Text] [Related]
37. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone. Araki S, Chikazawa K, Motoyama M, Ijima K, Abe N, Tamada T. J Clin Endocrinol Metab; 1985 Mar 20; 60(3):590-8. PubMed ID: 3919050 [Abstract] [Full Text] [Related]
38. Progesterone and LH variations after LH-RH administration in the luteal phase of the menstrual cycle. Caruso A, Lanzone A, Fulghesu AM, Pilloni MD, Rassu G, Mancuso S. Horm Res; 1986 Mar 20; 24(1):18-25. PubMed ID: 3530934 [Abstract] [Full Text] [Related]
39. The corpus luteum of the primate menstrual cycle is capable of recovering from a transient withdrawal of pituitary gonadotropin support. Hutchison JS, Zeleznik AJ. Endocrinology; 1985 Sep 20; 117(3):1043-9. PubMed ID: 3893990 [Abstract] [Full Text] [Related]